Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Exploring the genetic alterations of Gorham-Stout disease
Olivia Pagliarosi1, Jessica Pepe1, Andrea Del Fattore2
1Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University, Rome, Italy.
Gorham-Stout disease (GSD), or vanishing bone disease, involves bone loss and abnormal vessel growth. This review details genetic mutations linked to GSD, potentially aiding diagnosis and treatment.
Area of Science:
- * Genetics
- * Rare Diseases
- * Osteology
Background:
- * Gorham-Stout disease (GSD), also known as vanishing bone disease, is a rare condition.
- * Characterized by extensive lymphatic and angiomatous proliferation leading to progressive osteolysis (bone loss).
- * Etiopathogenesis and definitive diagnostic criteria remain challenging due to its rarity and complex presentation.
Purpose of the Study:
- * To review and consolidate reported genetic alterations in Gorham-Stout disease patients.
- * To explore the association between identified genetic mutations and the clinical manifestations of GSD.
- * To highlight the potential of genetic findings in improving GSD diagnosis and treatment strategies.
Main Methods:
- * Comprehensive literature search for studies reporting genetic findings in Gorham-Stout disease.
- * Analysis of identified genetic mutations and their correlation with clinical phenotypes.
- * Synthesis of current knowledge on the genetic basis of GSD.
Main Results:
- * Compilation of various genetic mutations reported in Gorham-Stout disease patients.
- * Examination of potential links between specific genetic alterations and disease characteristics.
- * Identification of emerging molecular pathways implicated in GSD.
Conclusions:
- * Genetic alterations are increasingly recognized in Gorham-Stout disease.
- * Understanding these genetic factors is crucial for advancing GSD diagnosis.
- * Further research into GSD's genetic basis may unlock targeted therapeutic approaches.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pleiotropy
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Translation
Translation Produces the Building Blocks of Life
Proteins are...